Karina Tuz

Title: Karina Tuz: Innovator in Viral Deactivation Technologies

Introduction

Karina Tuz is a prominent inventor based in Buffalo Grove, IL (US). She has made significant contributions to the field of virology through her innovative research and development of methods to deactivate enveloped viruses, including SARS-CoV-2. Her work is crucial in the ongoing fight against viral infections.

Latest Patents

Karina Tuz holds a patent for "Compositions and methods for deactivating enveloped viruses such as SARS-CoV-2." This invention includes a composition and method for preventing and treating infections caused by enveloped viruses. The invention features compounds that have a catalytic domain of a glycosidase and a binding domain that attaches the compound to the surface of the targeted virus. Additionally, it encompasses a pharmaceutical formulation that includes the compound and a pharmaceutically acceptable carrier to deliver the active portion to the infecting virus within an infected human or animal. The formulation can be administered as an inhalant or a nasal spray. Furthermore, the invention outlines methods for using a glycosidase or its catalytic part to deactivate enveloped viruses by removing glycans from the viral surface protein.

Career Highlights

Karina Tuz is affiliated with the Illinois Institute of Technology, where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health and safety.

Collaborations

Karina collaborates with notable colleagues, including Oscar Juarez and David Do Le Minh, who contribute to her research initiatives and projects.

Conclusion

Karina Tuz is a dedicated inventor whose work in viral deactivation technologies is paving the way for innovative treatments against viral infections. Her contributions are vital in enhancing public health measures and combating emerging viral threats.